Order Article Reprints

Rayson D, Bertin J, Lemelin M, Tong M, Ng R, Ding P, Cheung WY, Sharma A, On PV, Feugère G, et al. Real-World Utilization of Palbociclib as First-Line Treatment for Canadian HR+/HER2− Women with Metastatic Breast Cancer: Results from PALCAN Study. Current Oncology. 2026; 33(2):81. https://doi.org/10.3390/curroncol33020081

Rayson, Daniel, Jonathan Bertin, Maxim Lemelin, Madeline Tong, Ryan Ng, Philip Ding, Winson Y. Cheung, Arushi Sharma, Phu Vinh On, Guillaume Feugère, and et al. 2026. "Real-World Utilization of Palbociclib as First-Line Treatment for Canadian HR+/HER2− Women with Metastatic Breast Cancer: Results from PALCAN Study" Current Oncology 33, no. 2: 81. https://doi.org/10.3390/curroncol33020081

Rayson, D., Bertin, J., Lemelin, M., Tong, M., Ng, R., Ding, P., Cheung, W. Y., Sharma, A., On, P. V., Feugère, G., & Lupichuk, S. (2026). Real-World Utilization of Palbociclib as First-Line Treatment for Canadian HR+/HER2− Women with Metastatic Breast Cancer: Results from PALCAN Study. Current Oncology, 33(2), 81. https://doi.org/10.3390/curroncol33020081